– FINLAND, Helsinki – Silmäasema (HEL: SILMA) today announced that its Board of Directors appointed Teppo Lindén as CEO as of 30 January 2020.
In addition, Ulla Näpänkangas and Jari-Pekka Kelhä will join the Management Team as of 30 January 2020.
“We want to thank Jussi Salminen for the great job he has successfully done during the last twelve months. Reinforcement of the Management Team and the CEO change is made to strengthen the management in this changed situation,” said Antti Kummu, Chairman.
About Dr Teppo Lindén
Teppo Lindén is an M.D., Specialist in Surgery, Orthopedics and Traumatology, with decades of experience of practicing and leading the medical business. Lindén is also the CEO of Coronaria Oy and Cor Group Oy. Lindén is vice chairman of the Silmäasema Oyj Board of Directors since 26 November 2019.
The new CEO of Silmäasema Optiikka Oy’s and a member of Silmäasema Oyj’s Management Team is Jari-Pekka Kelhä, with years of experience of optical retail business. Kelhä is a Master of Laws and has been the CEO of Coronaria Optical Group and Health City Finland Oy, which is a subsidiary of Cor Group.
The new CEO of Silmäasema Sairaala Oy and a member of Silmäasema Oyj’s Management Team is M.D. and Ophthalmologist Ulla Näpänkangas. Näpänkangas is also the CEO of Coronaria Silmäklinikka Oy. Lindén is a member of Silmäasema Oyj Board of Directors since 26 November 2019.
“Lindén, Kelhä and Näpänkangas will bring sector know-how and they will complement and reinforce the capabilities of the Management Team to run and develop the optical retail and eye clinics. We see both businesses highly synergic and we believe this set-up of having both optical retail and eye clinics,” said Kummu.
Coronaria owns over 90 percent of the issued and outstanding shares of Silmäasema Oyj and it has a redemption right to redeem the remaining Silmäasema minority shares in accordance with provisions of the Finnish Limited Liability Companies Act. Coronaria has announced by a market notice dated 25 November 2019 its intention to acquire all the shares in Silmäasema and to cause Silmäasema to apply for delisting of its shares from Nasdaq Helsinki Ltd. Coronaria is part of Cor Group.
About Silmäasema
Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain in Finland. The Silmäasema chain has nearly 150 stores and 13 eye clinics in Finland as well as eight stores in Estonia. The Silmäasema chain employs over 1,000 eye, healthcare professionals. The Silmäasema Group’s net sales were EUR 122.9 million in 2018 and adjusted EBITDA was EUR 11.8 million.
For more information: https://www.silmaasema.fi
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
